Essity AB Series B
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, wet wipes, wash glo… Read more
Essity AB Series B (0RQD) - Total Liabilities
Latest total liabilities as of December 2021: Skr115.18 Billion SEK
Based on the latest financial reports, Essity AB Series B (0RQD) has total liabilities worth Skr115.18 Billion SEK as of December 2021.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Essity AB Series B - Total Liabilities Trend (2017–2021)
This chart illustrates how Essity AB Series B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Essity AB Series B Competitors by Total Liabilities
The table below lists competitors of Essity AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ovintiv Inc
NYSE:OVV
|
USA | $9.15 Billion |
|
Mr. Cooper Group Inc
NASDAQ:COOP
|
USA | $13.40 Billion |
|
Affirm Holdings Inc
NASDAQ:AFRM
|
USA | $9.41 Billion |
|
Ralph Lauren Corp Class A
NYSE:RL
|
USA | $4.93 Billion |
|
UPM-Kymmene Oyj
PINK:UPMMY
|
USA | $7.20 Billion |
|
Julius Baer Gruppe AG
SW:BAER
|
Switzerland | CHF97.98 Billion |
|
Ralph Lauren Corp. Cl A
LSE:0KTS
|
UK | $4.93 Billion |
|
Mega Financial Holding Co Ltd
TW:2886
|
Taiwan | NT$4.42 Trillion |
Liability Composition Analysis (2017–2021)
This chart breaks down Essity AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.09 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.92 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Essity AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Essity AB Series B (2017–2021)
The table below shows the annual total liabilities of Essity AB Series B from 2017 to 2021.
| Year | Total Liabilities | Change |
|---|---|---|
| 2021-12-31 | Skr115.18 Billion | +14.84% |
| 2020-12-31 | Skr100.29 Billion | -7.28% |
| 2019-12-31 | Skr108.17 Billion | +0.98% |
| 2018-12-31 | Skr107.12 Billion | +2.29% |
| 2017-12-31 | Skr104.73 Billion | -- |